Intestinal SR-BI does not impact cholesterol absorption or transintestinal cholesterol efflux in mice

Journal of Lipid Research

Volumn 54, Issue 6, 2013, Pages 1567-1577

  Bura, Kanwardeep S ^a   Lord, Caleb ^a   Marshall, Stephanie ^a   McDaniel, Allison ^a   Thomas, Gwyn ^a   Warrier, Manya ^a   Zhang, Jun ^a   Davis, Matthew A ^a   Sawyer, Janet K ^a   Shah, Ramesh ^a   Wilson, Martha D ^a   Dikkers, Arne ^b   Tietge, Uwe J F ^b   Collet, Xavier ^c   Rudel, Lawrence L ^a   Temel, Ryan E ^a   Brown, J Mark ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c University Hospital of Toulouse   (France)

Author keywords

Fecal neutral sterol excretion; Reverse cholesterol transport; Scavenger receptor class B type I

Indexed keywords

CHOLESTEROL; EZETIMIBE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI; STEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; EXCRETION; FECES; IMMUNOBLOTTING; IMMUNOLOCALIZATION; LIPID ABSORPTION; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE; TRANSINTESTINAL CHOLESTEROL EFFLUX; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

FECAL NEUTRAL STEROL EXCRETION; REVERSE CHOLESTEROL TRANSPORT; SCAVENGER RECEPTOR CLASS B TYPE I;

ANIMALS; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL; INTESTINAL ABSORPTION; INTESTINES; MICE; MICE, TRANSGENIC; SCAVENGER RECEPTORS, CLASS B;

EID: 84877905245     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M034454     Document Type: Article

References (73)

1. Roger, V. L., A. S. Go, D. M. Lloyd-Jones, E. J. Benjamin, J. D. Berry, W. B. Borden, D. M. Bravata, S. Dai, E. S. Ford, C. S. Fox, et al. 2012. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 125: e1002.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2002. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 106: 3143-3421.
3. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62: 707-714. (Pubitemid 8110784)
4. Rosenson, R. S., H. B. Brewer, Jr., W. S. Davidson, Z. A. Fayad, V. Fuster, J. Goldstein, M. Hellerstein, X. C. Jiang, M. C. Phillips, D. J. Rader, et al. 2012. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation. 125: 1905-1919.
5. Barter, P. J., S. Nicholls, K. A. Rye, G. M. Anantharamaiah, M. Navab, and A. M. Fogelman. 2004. Antiinflammatory properties of HDL. Circ. Res. 95: 764-772. (Pubitemid 39390578)
6. Yvan-Charvet, L., N. Wang, and A. R. Tall. 2010. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler. Thromb. Vasc. Biol. 30: 139-143.
7. Dietschy, J. M., and S. D. Turley. 2002. Control of cholesterol turnover in the mouse. J. Biol. Chem. 277: 3801-3804. (Pubitemid 34968627)
8. Wang, X., and D. J. Rader. 2007. Molecular regulation of macrophage reverse cholesterol transport. Curr. Opin. Cardiol. 22: 368-372. (Pubitemid 46897290)
9. Jolley, C. D., L. A. Woollett, S. D. Turley, and J. M. Dietschy. 1998. Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration. J. Lipid Res. 39: 2143-2149. (Pubitemid 28523120)
10. Groen, A. K., V. W. Bloks, R. H. Bandsma, R. Ottenhoff, G. Chimini, and F. Kuipers. 2001. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J. Clin. Invest. 108: 843-850. (Pubitemid 32880293)
11. Xie, C., S. D. Turley, and J. M. Dietschy. 2009. ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse. J. Lipid Res. 50: 1316-1329.
12. Vrins, C. L., R. Ottenhoff, K. van den Oever, D. R. de Waart, J. K. Kruyt, Y. Zhao, T. J. Van Berkel, L. M. Havekes, J. M. Aerts, M. Van Eck, et al. 2012. Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein. J. Lipid Res. 53: 2017-2023.
13. Temel, R. E., W. Tang, Y. Ma, L. L. Rudel, M. C. Willingham, Y. A. Ioannou, J. P. Davies, L. M. Nilsson, and L. Yu. 2007. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentrations and is a target of ezetimibe. J. Clin. Invest. 117: 1968-1978. (Pubitemid 47036331)
14. Temel, R. E., J. K. Sawyer, L. Yu, C. Lord, C. Degirolamo, A. McDaniel, S. Marshall, N. Wang, R. Shah, L. L. Rudel, et al. 2010. Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Cell Metab. 12: 96-102.
15. Brown, J. M., T. A. Bell III, H. M. Alger, J. K. Sawyer, T. L. Smith, K. Kelley, R. Shah, M. D. Wilson, M. A. Davis, R. G. Lee, et al. 2008. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss. J. Biol. Chem. 283: 10522-10534.
16. Kruit, J. K., T. Plosch, R. Havinga, R. Boverhof, P. H. Groot, A. K. Groen, and F. Kuipers. 2005. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Gastroenterology. 128: 147-156. (Pubitemid 40039966)
17. Mauad, T. H., C. M. van Nieuwkerk, K. P. Dingemans, J. J. Smit, A. H. Schinkel, R. G. Notenboom, M. A. van den Bergh Weerman, R. P. Verkruisen, A. K. Groen, and R. P. Oude Elferink. 1994. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am. J. Pathol. 145: 1237-1245.
18. Yu, L., R. E. Hammer, J. Li-Hawkins, K. Von Bergmann, D. Lutjohann, J. C. Cohen, and H. H. Hobbs. 2002. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. USA. 99: 16237-16242. (Pubitemid 35462779)
19. van der Velde, A. E., C. L. Vrins, K. van den Oever, C. Kunne, R. P. Oude Elferink, F. Kuipers, and A. K. Groen. 2007. Direct intestinal cholesterol secretion contributes significantly to total fecal neutral sterol excretion in mice. Gastroenterology. 133: 967-975. (Pubitemid 47374133)
20. van der Velde, A. E., C. L. Vrins, K. van den Oever, I. Seeman, R. P. Oude Elferink, M. van Eck, F. Kuipers, and A. K. Groen. 2008. Regulation of direct transintestinal cholesterol excretion in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G203-G208.
21. van der Veen, J. N., T. H. van Dijk, C. L. Vrins, H. van Meer, R. Havinga, K. Bijsterveld, U. J. Tietge, A. K. Groen, and K. Kuipers. 2009. Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol. J. Biol. Chem. 284: 19211-19219.
22. Vrins, C. L., A. E. van der Velde, K. van den Oever, J. H. Levels, S. Huet, R. P. Oude Elferink, F. Kuipers, and A. K. Groen. 2009. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux. J. Lipid Res. 50: 2046-2054.
23. Temel, R. E., and J. M. Brown. 2012. Biliary and nonbiliary contributions to reverse cholesterol transport. Curr. Opin. Lipidol. 23: 85-90.
24. Brufau, G., A. K. Groen, and F. Kuipers. 2011. Reverse cholesterol transport revisited: contribution of biliary versus intestinal cholesterol excretion. Arterioscler. Thromb. Vasc. Biol. 31: 1726-1733.
25. Cooper, A. D. 1991. Metabolic basis of cholesterol gallstone disease. Gastroenterol. Clin. North Am. 20: 21-46.
26. Hayes, K. C., A. Livingston, and E. A. Trautwein. 1992. Dietary impact on biliary lipids and gallstones. Annu. Rev. Nutr. 12: 299-326.
27. Groen, A., C. Kunne, G. Jongsma, K. van den Oever, K. S. Mok, M. Petruzzelli, C. Vrins, L. Bull, C. C. Paulusma, and R. P. Oude Elferink. 2008. Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice. Gastroenterology. 134: 2091-2100. (Pubitemid 351783264)
28. Annema, W., and U. J. Tietge. 2012. Regulation of reverse cholesterol transport-a comprehensive appraisal of available animal studies. Nutr. Metab. (Lond). 9: 25.
29. Calvo, D., and M. A. Vega. 1993. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J. Biol. Chem. 268: 18929-18935. (Pubitemid 23273842)
30. Acton, S. L., P. E. Scherer, H. F. Lodish, and M. Krieger. 1994. Expression cloning of SR-BI, a CD36 related class B scavenger receptor. J. Biol. Chem. 269: 21003-21009. (Pubitemid 24266467)
31. Landschulz, K. T., R. K. Pathak, A. Rigotti, M. Krieger, and H. H. Hobbs. 1996. Regulation of scavenger receptor, class B type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Invest. 98: 984-995. (Pubitemid 26293317)
32. Silver, D. L., N. Wang, X. Xiao, and A. R. Tall. 2001. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type I results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J. Biol. Chem. 276: 25287-25293.
33. Burgos, P. V., C. Klattenhoff, E. de la Fuente, A. Rigotti, and A. Gonzalez. 2004. Cholesterol depletion induces PKA-mediated basolateral-to-apical transcytosis of the scavenger receptor class B type I in MDCK cells. Proc. Natl. Acad. Sci. USA. 101: 3845-3850. (Pubitemid 38381065)
34. Harder, C. J., A. Meng, P. Rippstein, H. M. McBride, and R. McPherson. 2007. SR-BI undergoes cholesterol-stimulated transcytosis to the bile canaliculus in polarized WIF-B cells. J. Biol. Chem. 282: 1445-1455. (Pubitemid 47076552)
35. Wüstner, D., M. Mondal, A. Huang, and F. R. Maxfield. 2004. Different transport routes for high density lipoprotein and its associated free sterol in polarized hepatic cells. J. Lipid Res. 45: 427-437. (Pubitemid 38337989)
36. Cai, S. F., R. J. Kirby, P. N. Howles, and D. Y. Hui. 2001. Differentiation-dependent expression and localization of the class B type I scavenger receptor in the intestine. J. Lipid Res. 42: 902-909. (Pubitemid 32545845)
37. Sehayek, E., R. Wang, J. G. Ono, V. S. Zinchuk, E. M. Duncan, S. Shefer, D. E. Vance, M. Ananthanarayanan, B. T. Chait, and J. L. Breslow. 2003. Localization of the PE methylation pathway and SR-BI to the canalicular membrane: evidence for apical PC biosynthesis that may promote biliary excretion of phospholipids and cholesterol. J. Lipid Res. 44: 1605-1613.
38. Rigotti, A., B. Trigatti, and J. Babitt. 1997. Scavenger receptor BI: a cell surface receptor for high density lipoprotein. Curr. Opin. Lipidol. 8: 181-188. (Pubitemid 27290465)
39. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
40. Liu, B., and M. Krieger. 2002. Highly purified scavenger receptor class B, type I reconstituted into phosphatidylcholine/cholesterol liposomes mediates high affinity high density lipoprotein binding and selective lipid uptake. J. Biol. Chem. 277: 34125-34135.
41. Kozarsky, K. F., M. H. Donahee, A. Rigotti, S. N. Iqbal, E. R. Edelman, and M. Krieger. 1997. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature. 387: 414-417. (Pubitemid 27227207)
42. Ji, Y., N. Wang, R. Ramakrishnan, E. Sehayek, D. Huszar, J. L. Breslow, and A. R. Tall. 1999. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J. Biol. Chem. 274: 33398-33402. (Pubitemid 129511644)
43. Wang, N., T. Arai, Y. Ji, F. Rinninger, and A. R. Tall. 1998. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J. Biol. Chem. 273: 32920-32926. (Pubitemid 28557684)
44. Ueda, Y., L. Royer, E. Gong, J. Zhang, P. N. Cooper, O. Francone, and E. M. Rubin. 1999. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J. Biol. Chem. 274: 7165-7171.
45. Wiersma, H., A. Gatti, N. Nijstad, R. P. Oude Elferink, F. Kuipers, and U. J. Tietge. 2009. Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice. Hepatology. 50: 1263-1272.
46. Ueda, Y., E. Gong, L. Royer, P. N. Cooper, O. Francone, and E. M. Rubin. 2000. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J. Biol. Chem. 275: 20368-20373. (Pubitemid 30457612)
47. Arai, T., N. Wang, M. Bezouevski, C. Welch, and A. R. Tall. 1999. Decreased atherosclerosis in heterozygous low-density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J. Biol. Chem. 274: 2366-2371.
48. Kozarsky, K. F., M. H. Donahee, J. M. Glick, M. Krieger, and D. J. Rader. 2000. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 20: 721-727. (Pubitemid 30151687)
49. Rigotti, A., B. L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger. 1997. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. USA. 94: 12610-12615. (Pubitemid 27492576)
50. Varban, M. L., F. Rinninger, N. Wang, V. Fairchild-Huntress, J. H. Dunmore, Q. Fang, M. L. Gosselin, K. L. Dixon, J. D. Deeds, S. L. Acton, et al. 1998. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 95: 4619-4624. (Pubitemid 28207962)
51. Trigatti, B., H. Rayburn, M. Vinals, A. Braun, H. Miettinen, M. Penman, M. Hertz, M. Schrenzel, L. Amigo, A. Rigotti, et al. 1999. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc. Natl. Acad. Sci. USA. 96: 9322-9327. (Pubitemid 29374753)
52. Braun, A., B. L. Trigatti, M. J. Post, K. Sato, M. Simons, J. M. Edelberg, R. D. Rosenberg, M. Schrenzel, and M. Krieger. 2002. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ. Res. 90: 270-276. (Pubitemid 34633927)
53. Zhang, S., M. H. Picard, E. Vasile, Y. Zhu, R. L. Raffai, K. H. Weisgraber, and M. Krieger. 2005. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice. Circulation. 111: 3457-3464. (Pubitemid 40923400)
54. Zhang, Y., J. R. Da Silva, M. Reilly, J. T. Billheimer, G. H. Rothblat, and D. J. Rader. 2005. Hepatic overexpression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 115: 2870-2874. (Pubitemid 41434414)
55. Hauser, H., J. H. Dyer, A. Nandy, A. A. Vega, M. Werder, E. Bieliauskaite, F. E. Weber, S. Compassi, A. Gemperli, D. Boffelli, et al. 1998. Indentification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry. 37: 17843-17850. (Pubitemid 29023939)
56. Labonté, E. D., P. N. Howles, N. A. Granholm, J. C. Rojas, J. P. Davies, Y. A. Ioannou, and D. Y. Hui. 2007. Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles. Biochim. Biophys. Acta. 1771: 1132-1139. (Pubitemid 47404960)
57. Mardones, P., V. Quinones, L. Amigo, M. Moreno, J. F. Miquel, M. Schwarz, H. E. Miettinen, B. Trigatti, M. Krieger, S. VanPatten, et al. 2001. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J. Lipid Res. 42: 170-180. (Pubitemid 32206827)
58. Altmann, S. W., H. R. Davis, Jr., X. Yao, M. Laverty, D. S. Compton, L. J. Zhu, J. H. Crona, M. A. Caplen, L. M. Hoos, G. Tetzloff, et al. 2002. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim. Biophys. Acta. 1580: 77-93. (Pubitemid 34260848)
59. Bietrix, F., D. Yan, M. Nauze, C. Rolland, J. Bertrand-Michel, C. Comera, S. Schaak, R. Barbaras, A. K. Groen, B. Perret, et al. 2006. Accelerated lipid absorption in mice overexpressing intestinal SR-BI. J. Biol. Chem. 281: 7214-7219. (Pubitemid 43847488)
60. Brown, J. M., S. Chung, J. K. Sawyer, C. Degirolamo, H. M. Alger, T. Nguyen, X. Zhu, M. Duong, A. L. Wibley, R. Shah, et al. 2008. Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis. Circulation. 118: 1467-1475.
61. Temel, R. E., R. G. Lee, K. L. Kelley, M. A. Davis, R. Shah, J. K. Sawyer, M. D. Wilson, and L. L. Rudel. 2005. Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2. J. Lipid Res. 46: 2423-2431. (Pubitemid 41532530)
62. Wiersma, H., A. Gatti, N. Nijstad, F. Kuipers, and U. J. Tietge. 2009. Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice. J. Lipid Res. 50: 1571-1580.
63. Carr, T. P., C. J. Andresen, and L. L. Rudel. 1993. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extract. Clin. Biochem. 26: 39-42. (Pubitemid 23060970)
64. Turley, S. D., and J. M. Dietschy. 1978. Re-evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for total bile acids in bile. J. Lipid Res. 19: 924-928. (Pubitemid 9028249)
65. Hayashi, A. A., J. Webb, J. Choi, C. Baker, M. Lino, B. Trigatti, K. E. Trajcevski, T. J. Hawke, and K. Adeli. 2011. Intestinal SR-BI is upregulated in insulin-resistant states and is associated with overproduction of intestinal apoB48-containing lipoproteins. Am. J. Physiol. Gastrointest. Liver Physiol. 301: G326-G337.
66. Chajek-Shaul, T., T. Hayek, A. Walsh, and J. L. Breslow. 1991. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters. Proc. Natl. Acad. Sci. USA. 88: 6731-6735. (Pubitemid 21915023)
67. Nijstad, N., T. Gautier, F. Briand, D. J. Rader, and U. J. Tietge. 2011. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice. Gastroenterology. 140: 1043-1051.
68. Osono, Y., L. A. Woollett, J. Herz, and J. M. Dietschy. 1995. Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J. Clin. Invest. 95: 1124-1132.
69. Zelcer, N., C. Hong, R. Boyadjian, and P. Tontonoz. 2009. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science. 325: 100-104.
70. Nguyen, D. V., V. A. Drover, M. Knopfel, P. Dhanasekaran, H. Hauser, and M. C. Phillips. 2009. Influence of class B scavenger receptors on cholesterol flux across brush border membrane and intestinal absorption. J. Lipid Res. 50: 2235-2244.
71. Béaslas, O., C. Cueille, F. Delers, D. Chateau, J. Chambaz, M. Rousset, and V. Carrière. 2009. Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1. PLoS ONE. 4: e4278.
72. Yuhanna, I. S., Y. Zhu, B. E. Cox, L. D. Hahner, S. Osborne-Lawrence, P. Lu, Y. L. Marcel, R. G. Anderson, M. E. Medelsohn, H. H. Hobbs, et al. 2001. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat. Med. 7: 853-857. (Pubitemid 32691642)
73. Saddar, S., V. Carriere, W. R. Lee, K. Tanigaki, I. S. Yuhanna, S. Parathath, E. Morel, M. Warrier, J. K. Sawyer, R.D. Gerard, et al. 2013. Scavenger receptor class B type I is a plasma membrane cholesterol sensor. Circ. Res. 112: 140-151.